The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1274
ISSUE1274
November 19, 2007
Formoterol (Perforomist) for COPD
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Formoterol (Perforomist) for COPD
November 19, 2007 (Issue: 1274)
Formoterol fumarate (Perforomist - Dey), a long-acting beta2-agonist, was recently approved by the FDA as an inhalation solution for nebulization for maintenance treatment of bronchoconstriction associated with chronic obstructive pulmonary disease...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.